New Vaccine Shows Promise Against Aggressive Form of Breast Cancer
A new vaccine tested on 18 women with triple-negative breast cancer triggered a strong immune response, according to researchers who say 16 participants remain cancer-free three years after treatment.
Health News is provided as a service to Nipomo Rexall Drug site users by HealthDay. Nipomo Rexall Drug nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.